ValuationViz

AXSM fund manager activity

Axsome Therapeutics, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q2 2019 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalNew3,000$734,3100.00%Aug 14, 2026
Joel Greenblatt - Gotham Asset ManagementNew980$239,8750.00%Aug 14, 2026
Polen Capital ManagementAdded4,468$1,093,6320.01%Aug 4, 2026
Torray FundsAdded14,928$3,653,9270.49%Jul 30, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Polen Capital ManagementNew2,116$357,6460.00%May 14, 2026
Torray FundsTrimmed14,774$2,497,1010.37%May 1, 2026

Older quarters